HT Capital
VC Fund
Shanghai, China
HT Capital is a VC fund in Shanghai focused on Health Care and Life Science. Huantao Investment Management
- Total investments:
- 11
- Last investment:
- Lead investor:
- 9%
Last updated:
For AI agents: llms.txt
Industries HT Capital invests in
Stages HT Capital invests in
Countries HT Capital invests in
Investment Focus
Industry
- Health Care 2 (18%)
- Life Science 2 (18%)
- Biotechnology 2 (18%)
- Manufacturing 2 (18%)
- Pharmaceutical 2 (18%)
Stage
- Series A 5 (45%)
- Series B 4 (36%)
- Angel 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Microview
|
Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment. | $13.7M / Series A / Oct 24, 2023 | |
Healsun Biopharm
|
Healsun Biopharm is a pharmaceutical company development processes such as molecular construction, stable cell line screening, cell culture process development, protein purification and process development, antibody-coupled drug process development and bioanalytical method development. | $36.8M / Series B / Aug 18, 2022 | |
Alebund Pharmaceuticals
|
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions. | $54.5M / Series B / Sep 13, 2021 | |
SVOLT
|
SVOLT manufacturer of electric batteries. They specialize in the manufacturing of automotive power batteries and energy storage systems. Their market applications include passenger cars, commercial vehicles, energy storage, and light power solutions. Their products include batteries and energy storage batterie. They provide users with energyvehicle charging piles, batteries recycling, and solutions. | $540.2M / Series A / Feb 26, 2021 | |
RecBio
|
Focusing on major innovative vaccines with independent intellectual property rights. | $226M / Series B / Nov 11, 2020 | |
China Intercontinental Cultural Communication
|
China Intercontinental Cultural Communication is an information platform of entertainment, history, art and other cultural information. | $425K / Angel / Oct 18, 2016 | |
|
Zhinengguo
|
Finance | Series A / Dec 30, 2015 | |
|
Qukaidan
|
Enterprise service | $30M / Series B / Nov 04, 2015 | |
|
Qukaidan
|
Enterprise service | $25M / Series B / Dec 17, 2014 | |
Beijing Qiandaibao Payment Technology
|
Beijing Qiandaibao Payment Technology Ltd. develops, designs, and manufactures mobile point of sale payment technology products. The company provides a smart phone plug-in that takes payments from mag-stripe cards. It also offers SIM-sticking card, SD card, smart-key, mobile-connecting card reader, card-swiping mobile phone. The company wasformerly known as Qiandaiwang (Beijing) Information Technology Co., Limited. | Series A / Nov 26, 2014 | |
| See all 11 investments → | |||
Co-Investors
IDG Capital
5 deals together
Gaorong Capital
2 deals together
BioVenture
2 deals together
Ping An Ventures
2 deals together
3E Bioventures
1 deal together
3H Health Investment
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does HT Capital invest in?
HT Capital invests primarily in Health Care, Life Science and Biotechnology startups, most often at Series A and Series B stage. Most of the 11 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did HT Capital last invest?
The most recent investment recorded for HT Capital closed in Oct 2023. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
